-24.8%
SNAP vs GSK
+26.4%
-51.2%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -2.7% | +2.0% | -0.9% |
| 7D | +1.5% | -4.2% | +5.7% | +1.2% |
| 30D | +1.9% | -7.5% | +9.4% | +1.2% |
| 3M | -3.9% | -3.3% | -0.6% | -3.9% |
| 6M | +5.2% | -9.3% | +14.6% | +4.0% |
| YTD | -32.7% | +1.6% | -34.3% | -32.0% |
| 1Y | -24.8% | +25.5% | -50.3% | -14.5% |
| All | -24.8% | +26.4% | -51.2% | -14.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling